Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.48 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.12.
Market Cap
8.48T
Revenue
4.59T
Profits
201.31B
PE Ratio
42.12
Profit Margin
4.39%
Dividend Yield
0.42%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -0.32% | 3,167,066 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 567.28B | -2.16% | 7,726,411 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 391.50B | -2.70% | 5,261,372 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 373.28B | 1.19% | 6,780,148 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 283.78B | -2.79% | 15,395,697 | 65.77B |
| 6 | NVS | Novartis AG | 277.43B | -0.99% | 1,683,465 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 275.12B | -0.83% | 1,328,786 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 196.37B | 0.09% | 10,223,247 | 50.57B |
| 9 | AMGN | Amgen Inc. | 189.18B | -1.31% | 4,371,391 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 176.04B | 1.03% | 1,873,714 | 45.20B |
| 11 | ABT | Abbott Laboratories | 154.45B | 0.56% | 10,949,754 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 154.33B | -0.38% | 6,653,086 | 29.74B |
| 13 | PFE | Pfizer Inc. | 148.19B | -0.80% | 34,194,149 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 147.53B | 1.34% | 2,601,687 | 10.58B |
| 15 | CVS | CVS Health Corporation | 128.46B | -1.26% | 7,416,954 | 405.62B |
| 16 | DHR | Danaher Corporation | 128.18B | 0.56% | 3,931,639 | 24.78B |
| 17 | SYK | Stryker Corporation | 118.05B | -1.36% | 2,444,434 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 114.85B | -1.56% | 13,557,583 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 114.33B | 1.24% | 1,482,833 | 12.22B |
| 20 | SNY | Sanofi | 105.19B | -1.02% | 1,848,502 | 54.60B |
| 21 | GSK | GSK plc | 105.04B | -1.53% | 3,434,292 | 43.29B |
| 22 | MDT | Medtronic plc | 103.20B | 0.22% | 6,492,248 | 36.36B |
| 23 | MCK | McKesson Corporation | 91.29B | -0.54% | 824,638 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 87.28B | -0.54% | 1,020,018 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 86.51B | 0.72% | 1,883,839 | 76.39B |
| 26 | CI | The Cigna Group | 77.73B | -1.40% | 1,125,098 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 69.50B | -0.32% | 16,284,038 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.57B | 0.46% | 815,809 | 14.92B |
| 29 | ARGX | argenx SE | 54.92B | -1.04% | 423,155 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.76B | -0.09% | 1,817,982 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 53.02B | 1.14% | 2,397,252 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 50.19B | -0.88% | 2,102,133 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 49.68B | 1.37% | 2,929,781 | 6.30B |
| 34 | MDLN | Medline Inc. | 49.04B | 1.97% | 15,877,247 | 29.14B |
| 35 | HUM | Humana Inc. | 45.65B | 0.27% | 1,784,605 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.96B | 1.63% | 556,765 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 40.10B | -0.49% | 1,758,778 | 22.23B |
| 38 | HLN | Haleon plc | 39.90B | -0.66% | 10,764,103 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.23B | -2.71% | 5,241,832 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.42B | 1.75% | 1,118,495 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.88B | 0.58% | 1,530,094 | 7.23B |
| 42 | WAT | Waters Corporation | 35.13B | 0.63% | 653,394 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 34.03B | 4.02% | 2,131,789 | - |
| 44 | ZTS | Zoetis Inc. | 33.52B | 0.48% | 5,769,877 | 9.53B |
| 45 | ALC | Alcon Inc. | 32.50B | -0.84% | 1,838,195 | 10.63B |
| 46 | CNC | Centene Corporation | 31.31B | -2.75% | 6,468,165 | 178.33B |
| 47 | RPRX | Royalty Pharma plc | 31.25B | -1.09% | 1,948,725 | 2.44B |
| 48 | NTRA | Natera, Inc. | 31.07B | 2.31% | 1,017,277 | 2.50B |
| 49 | ONC | BeOne Medicines AG | 29.82B | 1.41% | 351,441 | 5.70B |
| 50 | IQV | IQVIA Holdings Inc. | 29.77B | -1.69% | 1,732,245 | 16.63B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.46B | -0.64% | 3,406,631 | 20.98B |
| 52 | BIIB | Biogen Inc. | 29.33B | -0.70% | 877,515 | 9.94B |
| 53 | DXCM | DexCom, Inc. | 28.64B | -1.53% | 5,388,471 | 4.82B |
| 54 | RMD | ResMed Inc. | 27.84B | -1.05% | 1,523,741 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 26.34B | 1.65% | 2,285,586 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 25.49B | 0.87% | 992,860 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 25.25B | 3.68% | 2,159,172 | 4.39B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.41B | 0.79% | 558,865 | 3.22B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.33B | 2.03% | 207,050 | 4.09B |
| 60 | UTHR | United Therapeutics Corporation | 23.33B | 0.66% | 351,707 | 3.17B |
| 61 | BNTX | BioNTech SE | 22.96B | 0.29% | 825,404 | 3.23B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.38B | -0.43% | 1,009,360 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.73B | -0.42% | 461,451 | 14.14B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.60B | -0.03% | 3,993,009 | 8.26M |
| 65 | INSM | Insmed Incorporated | 21.12B | -0.40% | 3,788,823 | 819.56M |
| 66 | MRNA | Moderna, Inc. | 20.68B | 4.45% | 6,342,069 | 2.23B |
| 67 | INCY | Incyte Corporation | 20.37B | -6.04% | 2,815,006 | 5.36B |
| 68 | STE | STERIS plc | 20.07B | -0.79% | 675,921 | 5.94B |
| 69 | VTRS | Viatris Inc. | 19.01B | -0.97% | 10,845,234 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.21B | -1.37% | 1,648,952 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.07B | -0.35% | 1,536,053 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.04B | -0.16% | 1,243,727 | 3.10B |
| 73 | THC | Tenet Healthcare Corporation | 15.43B | 2.55% | 1,492,588 | 21.46B |
| 74 | GMAB | Genmab A/S | 15.19B | -1.99% | 1,023,082 | 3.90B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.47B | 0.01% | 690,986 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 13.87B | 2.40% | 638,052 | 998.25M |
| 77 | DVA | DaVita Inc. | 13.47B | 0.52% | 846,399 | 13.84B |
| 78 | MEDP | Medpace Holdings, Inc. | 13.35B | 0.03% | 265,938 | 2.68B |
| 79 | BTSG | BrightSpring Health Services, Inc. | 13.35B | 1.34% | 2,533,365 | 13.65B |
| 80 | EXEL | Exelixis, Inc. | 13.32B | -0.24% | 2,025,445 | 2.38B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 1.80% | 3,087,105 | 579.96M |
| 82 | SOLV | Solventum Corporation | 13.32B | -2.50% | 1,399,884 | 8.26B |
| 83 | COO | The Cooper Companies, Inc. | 13.22B | -0.18% | 2,641,464 | 4.23B |
| 84 | AXSM | Axsome Therapeutics, Inc. | 13.04B | -0.69% | 628,243 | 708.24M |
| 85 | SNN | Smith & Nephew plc | 12.90B | -0.36% | 682,402 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.77B | 1.96% | 1,084,905 | 4.10B |
| 87 | FMS | Fresenius Medical Care AG | 12.68B | 1.87% | 730,452 | 22.32B |
| 88 | PEN | Penumbra, Inc. | 12.52B | -0.16% | 446,347 | 1.45B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.22B | 0.93% | 1,506,282 | 1.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.13B | 0.50% | 4,476,687 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.52B | 3.95% | 284,634 | 1.13B |
| 92 | ICLR | ICON Public Limited Company | 11.31B | 1.05% | 598,032 | 8.25B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.27B | 0.23% | 1,018,203 | 3.58B |
| 94 | RVTY | Revvity, Inc. | 11.22B | 0.89% | 942,357 | 2.90B |
| 95 | SMMT | Summit Therapeutics Inc. | 10.97B | 0.86% | 8,529,364 | - |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.87B | 3.53% | 1,115,909 | 622.01M |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.76B | -0.54% | 1,458,251 | 3.24B |
| 98 | BAX | Baxter International Inc. | 10.75B | -0.24% | 6,022,103 | 11.32B |
| 99 | MOH | Molina Healthcare, Inc. | 10.52B | 0.79% | 879,544 | 43.10B |
| 100 | GMED | Globus Medical, Inc. | 10.50B | -3.82% | 1,653,361 | 3.10B |
| 101 | PODD | Insulet Corporation | 10.26B | -1.04% | 1,041,096 | 2.90B |
| 102 | EHC | Encompass Health Corporation | 9.86B | -2.08% | 1,016,125 | 6.07B |
| 103 | NUVL | Nuvalent, Inc. | 9.74B | 0.08% | 2,969,479 | - |
| 104 | CYTK | Cytokinetics, Incorporated | 9.69B | 1.75% | 1,012,618 | 105.82M |
| 105 | KRYS | Krystal Biotech, Inc. | 9.57B | 2.13% | 263,461 | 417.30M |
| 106 | TEM | Tempus AI, Inc. | 9.39B | 9.41% | 10,292,877 | 1.36B |
| 107 | HSIC | Henry Schein, Inc. | 9.24B | -0.20% | 1,185,124 | 13.38B |
| 108 | CRL | Charles River Laboratories International, Inc. | 9.08B | 0.51% | 690,460 | 4.03B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.92B | 0.25% | 1,043,174 | 769.10M |
| 110 | UHS | Universal Health Services, Inc. | 8.84B | -0.31% | 1,009,377 | 17.76B |
| 111 | TECH | Bio-Techne Corporation | 8.79B | 4.02% | 3,278,900 | 1.21B |
| 112 | OSCR | Oscar Health, Inc. | 8.78B | 3.11% | 6,243,398 | 13.30B |
| 113 | ENSG | The Ensign Group, Inc. | 8.74B | 0.90% | 705,424 | 5.27B |
| 114 | BRKR | Bruker Corporation | 8.62B | 4.43% | 3,499,095 | 3.46B |
| 115 | RGC | Regencell Bioscience Holdings Limited | 8.47B | -9.24% | 154,871 | - |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.45B | 2.56% | 1,815,764 | 1.51B |
| 117 | ABVX | ABIVAX Société Anonyme | 7.87B | 1.77% | 2,123,977 | 5.67M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.74B | 1.17% | 226,464 | 2.59B |
| 119 | QGEN | Qiagen N.V. | 7.65B | -0.13% | 2,511,619 | 2.10B |
| 120 | GKOS | Glaukos Corporation | 7.64B | 2.63% | 801,977 | 551.35M |
| 121 | ATR | AptarGroup, Inc. | 7.54B | 0.31% | 576,140 | 3.87B |
| 122 | IBRX | ImmunityBio, Inc. | 7.47B | 0.42% | 8,140,230 | 140.98M |
| 123 | ALKS | Alkermes plc | 7.39B | 0.18% | 1,822,134 | 1.56B |
| 124 | RGEN | Repligen Corporation | 7.38B | 0.21% | 633,247 | 763.34M |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | -0.77% | 544,243 | 7.46M |
| 126 | HQY | HealthEquity, Inc. | 7.27B | -1.55% | 1,235,597 | 1.34B |
| 127 | SYRE | Spyre Therapeutics, Inc. | 7.26B | 3.45% | 1,148,881 | - |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 7.23B | 2.44% | 536,301 | 74.06M |
| 129 | PCVX | Vaxcyte, Inc. | 7.16B | 4.42% | 1,739,391 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.13B | 1.58% | 2,581,143 | 700.35M |
| 131 | KYMR | Kymera Therapeutics, Inc. | 7.04B | -0.70% | 485,139 | 51.48M |
| 132 | HIMS | Hims & Hers Health, Inc. | 6.98B | 12.49% | 22,980,154 | 2.37B |
| 133 | IMVT | Immunovant, Inc. | 6.87B | -0.54% | 1,220,282 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.81B | 0.14% | 798,588 | 1.55B |
| 135 | AVTR | Avantor, Inc. | 6.63B | 3.41% | 8,349,567 | 6.55B |
| 136 | LEGN | Legend Biotech Corporation | 6.59B | -1.09% | 1,449,792 | 1.14B |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.46B | -2.58% | 709,327 | - |
| 138 | GRFS | Grifols, S.A. | 6.45B | -0.26% | 394,478 | 8.58B |
| 139 | LQDA | Liquidia Corporation | 6.39B | 0.80% | 2,103,758 | 288.07M |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.37B | 2.17% | 3,590,702 | 827.11M |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 6.16B | 1.66% | 832,595 | 569.61M |
| 142 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.10% | 1,612,483 | 15.00M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | 1.49% | 2,259,556 | 217.17M |
| 144 | TFX | Teleflex Incorporated | 5.76B | -0.30% | 437,434 | 2.13B |
| 145 | PACS | PACS Group, Inc. | 5.74B | -0.08% | 1,129,257 | 5.43B |
| 146 | BLTE | Belite Bio, Inc | 5.67B | 4.40% | 242,482 | - |
| 147 | COGT | Cogent Biosciences, Inc. | 5.67B | 0.21% | 1,974,738 | - |
| 148 | CHE | Chemed Corporation | 5.60B | 1.00% | 311,323 | 2.54B |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.50B | 3.94% | 824,499 | - |
| 150 | BLCO | Bausch + Lomb Corporation | 5.35B | -0.53% | 292,179 | 5.21B |
| 151 | HNGE | Hinge Health, Inc. | 5.29B | 4.61% | 1,881,548 | 646.34M |
| 152 | CGON | CG Oncology, Inc. | 5.25B | 0.02% | 909,005 | 5.07M |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 5.18B | 0.25% | 2,370,233 | 3.05B |
| 154 | CAI | Caris Life Sciences, Inc. | 5.14B | 1.17% | 1,579,323 | 907.29M |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.08B | -0.90% | 159,041 | 274.48M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.07B | 5.64% | 1,828,503 | 4.10M |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 5.07B | 0.58% | 1,168,388 | 7.50M |
| 158 | TWST | Twist Bioscience Corporation | 5.03B | 6.07% | 2,642,770 | 409.48M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.00B | 3.38% | 2,105,873 | 536.20M |
| 160 | BLLN | BillionToOne, Inc. | 4.78B | 2.80% | 751,949 | 354.54M |
| 161 | TNGX | Tango Therapeutics, Inc. | 4.76B | 6.33% | 3,225,244 | 56.99M |
| 162 | SHC | Sotera Health Company | 4.63B | 0.25% | 1,782,904 | 1.19B |
| 163 | STVN | Stevanato Group S.p.A. | 4.54B | -2.63% | 561,081 | 1.39B |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | 0.49% | 764,490 | 1.34M |
| 165 | ERAS | Erasca, Inc. | 4.49B | 2.70% | 2,916,627 | - |
| 166 | RDNT | RadNet, Inc. | 4.49B | 0.60% | 841,125 | 2.14B |
| 167 | LIVN | LivaNova PLC | 4.38B | 0.39% | 755,835 | 1.43B |
| 168 | CELC | Celcuity Inc. | 4.30B | -0.35% | 1,112,708 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.21B | -1.06% | 1,019,958 | 3.10B |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.15B | -1.47% | 1,002,321 | - |
| 171 | TXG | 10x Genomics, Inc. | 4.09B | 11.72% | 4,479,148 | 638.78M |
| 172 | ALHC | Alignment Healthcare, Inc. | 4.09B | 0.15% | 4,684,948 | 4.26B |
| 173 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.03B | 0.87% | 627,222 | 754.05M |
| 174 | MANE | Veradermics, Incorporated | 4.02B | 0.21% | 305,136 | - |
| 175 | NVST | Envista Holdings Corporation | 4.02B | 0.33% | 2,065,701 | 2.81B |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.99B | 0.62% | 545,690 | 1.54B |
| 177 | VCYT | Veracyte, Inc. | 3.92B | 3.85% | 1,426,835 | 541.74M |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.03% | 2,817,696 | 596.96M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.79B | 1.09% | 933,723 | - |
| 180 | DOCS | Doximity, Inc. | 3.78B | 3.19% | 3,638,752 | 644.86M |
| 181 | IRTC | iRhythm Holdings, Inc. | 3.74B | 0.10% | 204,671 | 787.85M |
| 182 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.70B | 1.73% | 931,247 | 18.07M |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | 0.83% | 1,209,861 | 1.10B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.60B | 0.07% | 893,216 | 2.23B |
| 185 | ICUI | ICU Medical, Inc. | 3.59B | 1.05% | 195,887 | 2.16B |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.58B | 0.66% | 694,952 | 22.57M |
| 187 | WAY | Waystar Holding Corp. | 3.56B | -1.07% | 1,709,643 | 1.16B |
| 188 | OGN | Organon & Co. | 3.53B | - | 2,163,183 | 6.16B |
| 189 | DNLI | Denali Therapeutics Inc. | 3.53B | 2.59% | 1,448,823 | - |
| 190 | HAE | Haemonetics Corporation | 3.50B | -1.65% | 886,426 | 1.33B |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.44B | 3.06% | 1,177,829 | - |
| 192 | OPCH | Option Care Health, Inc. | 3.33B | 2.26% | 3,988,411 | 5.67B |
| 193 | LFST | LifeStance Health Group, Inc. | 3.33B | 1.06% | 2,225,996 | 1.49B |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.31B | -0.21% | 297,126 | 803.79M |
| 195 | RLAY | Relay Therapeutics, Inc. | 3.26B | 1.01% | 1,879,809 | 10.68M |
| 196 | BKD | Brookdale Senior Living Inc. | 3.25B | 1.34% | 5,096,611 | 3.00B |
| 197 | WRBY | Warby Parker Inc. | 3.24B | -0.30% | 3,063,984 | 890.57M |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 3.20B | 4.92% | 1,792,407 | 415.62M |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.18B | -8.25% | 1,280,672 | - |
| 200 | BEAM | Beam Therapeutics Inc. | 3.10B | 7.20% | 2,904,506 | 164.01M |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.10B | 2.97% | 1,643,986 | - |
| 202 | ITGR | Integer Holdings Corporation | 3.08B | -0.14% | 238,796 | 1.86B |
| 203 | GPCR | Structure Therapeutics Inc. | 3.06B | 0.33% | 711,915 | - |
| 204 | NHC | National HealthCare Corporation | 3.06B | -1.08% | 134,272 | 1.53B |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.04B | 1.60% | 1,218,647 | 236.00M |
| 206 | ALMS | Alumis Inc. | 2.93B | -4.76% | 1,557,660 | 8.40M |
| 207 | PRVA | Privia Health Group, Inc. | 2.90B | -1.75% | 1,171,039 | 2.25B |
| 208 | HTFL | HeartFlow, Inc. | 2.83B | -1.26% | 1,120,436 | 191.42M |
| 209 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | -0.80% | 2,852,779 | 295.41M |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 2.72B | -0.49% | 276,221 | 1.46B |
| 211 | IRON | Disc Medicine, Inc. | 2.68B | 3.09% | 464,050 | - |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 2.66B | -0.16% | 502,415 | 535.08M |
| 213 | IDYA | IDEAYA Biosciences, Inc. | 2.66B | 4.31% | 1,247,939 | 225.27M |
| 214 | TMDX | TransMedics Group, Inc. | 2.61B | 3.52% | 948,958 | 635.89M |
| 215 | DFTX | Definium Therapeutics, Inc. | 2.59B | -3.96% | 1,386,538 | - |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.58B | -8.17% | 2,790,506 | - |
| 217 | GRAL | GRAIL, Inc. | 2.57B | -0.07% | 668,648 | 156.12M |
| 218 | KLRA | Kailera Therapeutics, Inc. | 2.55B | 4.13% | 404,044 | - |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.55B | -1.24% | 902,284 | 776.83M |
| 220 | CLOV | Clover Health Investments, Corp. | 2.53B | 1.69% | 7,145,634 | 2.21B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.52B | 2.72% | 1,007,153 | 865.00K |
| 222 | RARE | Ultragenyx Pharmaceutical Inc. | 2.49B | 4.23% | 1,478,792 | 670.00M |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.48B | 2.52% | 449,495 | 229.58M |
| 224 | VERA | Vera Therapeutics, Inc. | 2.46B | -0.06% | 560,086 | - |
| 225 | AXGN | Axogen, Inc. | 2.33B | 1.72% | 2,883,070 | 238.11M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.30B | 4.14% | 4,153,927 | 885.72M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | 1.59% | 2,473,516 | 3.37B |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | -2.40% | 726,101 | 1.09B |
| 229 | PHVS | Pharvaris N.V. | 2.20B | 2.67% | 122,962 | - |
| 230 | KOD | Kodiak Sciences Inc. | 2.13B | - | 513,589 | - |
| 231 | PGNY | Progyny, Inc. | 2.11B | 1.05% | 1,373,026 | 1.29B |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.10B | -0.04% | 213,078 | 256.28M |
| 233 | NTLA | Intellia Therapeutics, Inc. | 2.08B | 23.20% | 16,409,533 | 66.09M |
| 234 | TRVI | Trevi Therapeutics, Inc. | 2.08B | 3.17% | 1,350,938 | - |
| 235 | NKTR | Nektar Therapeutics | 2.07B | 2.97% | 674,182 | 55.63M |
| 236 | SEM | Select Medical Holdings Corporation | 2.06B | -0.06% | 1,223,554 | 5.52B |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.14% | 1,122,685 | 298.30M |
| 238 | IMNM | Immunome, Inc. | 2.05B | -1.69% | 905,109 | 4.02M |
| 239 | NVCR | NovoCure Limited | 2.04B | -1.01% | 2,767,814 | 674.41M |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.03B | 0.50% | 2,947,663 | 3.68B |
| 241 | NEOG | Neogen Corporation | 2.02B | 2.20% | 1,241,823 | 870.56M |
| 242 | ZLAB | Zai Lab Limited | 1.99B | 3.87% | 637,971 | 453.28M |
| 243 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.81% | 985,836 | 899.11M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 1.97B | 1.27% | 1,758,275 | - |
| 245 | ADMA | ADMA Biologics, Inc. | 1.97B | 3.53% | 4,513,060 | 509.86M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 1.97B | 0.56% | 2,467,340 | 52.04M |
| 247 | SGRY | Surgery Partners, Inc. | 1.96B | -1.14% | 1,794,016 | 3.34B |
| 248 | VCEL | Vericel Corporation | 1.96B | 2.22% | 476,553 | 292.09M |
| 249 | MD | Pediatrix Medical Group, Inc. | 1.95B | 0.29% | 615,118 | 1.93B |
| 250 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -0.83% | 383,467 | 1.20B |
| 251 | AGL | agilon health, inc. | 1.91B | 1.27% | 312,320 | 5.82B |
| 252 | ASTH | Astrana Health, Inc. | 1.90B | -0.62% | 452,293 | 3.53B |
| 253 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 8.01% | 1,651,738 | 66.05M |
| 254 | NBTX | Nanobiotix S.A. | 1.87B | 5.11% | 118,954 | 38.27M |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.87B | 0.60% | 833,892 | 32.08M |
| 256 | BHC | Bausch Health Companies Inc. | 1.86B | -1.38% | 2,308,568 | 10.53B |
| 257 | MBX | MBX Biosciences, Inc. | 1.86B | 9.77% | 1,259,807 | - |
| 258 | HCM | HUTCHMED (China) Limited | 1.85B | -1.19% | 25,059 | 548.51M |
| 259 | RAPP | Rapport Therapeutics, Inc. | 1.83B | -0.36% | 317,189 | 20.00M |
| 260 | BHVN | Biohaven Ltd. | 1.83B | 7.62% | 4,471,544 | - |
| 261 | WGS | GeneDx Holdings Corp. | 1.82B | 2.34% | 980,030 | 442.68M |
| 262 | OMCL | Omnicell, Inc. | 1.82B | 5.71% | 943,179 | 1.23B |
| 263 | UFPT | UFP Technologies, Inc. | 1.81B | -0.54% | 168,663 | 608.85M |
| 264 | VRDN | Viridian Therapeutics, Inc. | 1.80B | -0.31% | 1,707,696 | 70.92M |
| 265 | IOVA | Iovance Biotherapeutics, Inc. | 1.80B | -1.23% | 12,659,269 | 285.61M |
| 266 | MESO | Mesoblast Limited | 1.79B | -1.22% | 123,903 | 65.38M |
| 267 | PLSE | Pulse Biosciences, Inc. | 1.79B | 6.38% | 362,948 | 751.00K |
| 268 | NUVB | Nuvation Bio Inc. | 1.79B | 4.47% | 4,183,452 | 143.05M |
| 269 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 0.53% | 2,683,970 | 71.78M |
| 270 | QURE | uniQure N.V. | 1.76B | 1.09% | 1,093,975 | 18.09M |
| 271 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | 4.44% | 15,393,576 | 66.41M |
| 272 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | 0.75% | 284,519 | 923.71M |
| 273 | GENB | Generate Biomedicines, Inc. | 1.74B | 9.69% | 619,340 | 30.30M |
| 274 | ADUS | Addus HomeCare Corporation | 1.73B | 1.66% | 260,365 | 1.45B |
| 275 | ANAB | AnaptysBio, Inc. | 1.73B | 6.14% | 668,556 | 232.39M |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 4.55% | 5,629,772 | 7.47M |
| 277 | PGEN | Precigen, Inc. | 1.71B | 7.87% | 6,770,942 | 31.60M |
| 278 | ZYME | Zymeworks Inc. | 1.70B | 1.66% | 526,420 | 81.26M |
| 279 | TYRA | Tyra Biosciences, Inc. | 1.70B | 5.78% | 987,113 | - |
| 280 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.69B | 4.11% | 2,918,682 | -665.00K |
| 281 | PVLA | Palvella Therapeutics, Inc. | 1.67B | 7.08% | 265,085 | - |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | 3.00% | 2,311,747 | 2.18B |
| 283 | INVA | Innoviva, Inc. | 1.65B | -1.41% | 709,835 | 420.69M |
| 284 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 1.26% | 1,953,136 | 217.17M |
| 285 | SION | Sionna Therapeutics, Inc. | 1.63B | 0.22% | 278,620 | - |
| 286 | SEPN | Septerna, Inc. | 1.62B | 0.22% | 287,771 | 72.26M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.61B | -1.34% | 606,031 | 367.34M |
| 288 | AAPG | Ascentage Pharma Group International | 1.61B | -1.48% | 11,560 | 82.08M |
| 289 | ABCL | AbCellera Biologics Inc. | 1.61B | 0.38% | 3,696,533 | 79.21M |
| 290 | CMPS | COMPASS Pathways plc | 1.59B | -2.40% | 2,077,374 | - |
| 291 | AVAH | Aveanna Healthcare Holdings Inc. | 1.57B | 1.97% | 1,272,731 | 2.52B |
| 292 | FTRE | Fortrea Holdings Inc. | 1.57B | 0.91% | 948,701 | 2.71B |
| 293 | CAPR | Capricor Therapeutics, Inc. | 1.55B | 3.57% | 987,067 | 11.13M |
| 294 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -0.66% | 745,302 | 42.95M |
| 295 | HCSG | Healthcare Services Group, Inc. | 1.53B | -0.40% | 649,810 | 1.85B |
| 296 | NVAX | Novavax, Inc. | 1.51B | 3.72% | 3,573,034 | 596.34M |
| 297 | URGN | UroGen Pharma Ltd. | 1.50B | 3.85% | 804,920 | 140.49M |
| 298 | PRGO | Perrigo Company plc | 1.48B | -2.64% | 2,725,915 | 4.18B |
| 299 | BFLY | Butterfly Network, Inc. | 1.47B | 1.62% | 6,463,283 | 102.92M |
| 300 | IMCR | Immunocore Holdings plc | 1.46B | -1.14% | 237,242 | 412.81M |
| 301 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 1,397,694 | 65.50M |
| 302 | HROW | Harrow, Inc. | 1.45B | 3.43% | 608,680 | 268.68M |
| 303 | NEO | NeoGenomics, Inc. | 1.44B | -0.54% | 834,529 | 745.97M |
| 304 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | -1.28% | 5,860,879 | - |
| 305 | ALMR | Alamar Biosciences, Inc. | 1.43B | -5.95% | 172,391 | 87.16M |
| 306 | ATRC | AtriCure, Inc. | 1.42B | -3.16% | 808,407 | 552.16M |
| 307 | BCAX | Bicara Therapeutics Inc. | 1.42B | -0.60% | 375,448 | - |
| 308 | ATAI | AtaiBeckley Inc. | 1.41B | -2.04% | 3,351,465 | 3.49M |
| 309 | MLTX | MoonLake Immunotherapeutics | 1.41B | 2.68% | 576,551 | - |
| 310 | STAA | STAAR Surgical Company | 1.41B | - | 418,786 | 290.38M |
| 311 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -0.79% | 352,606 | - |
| 312 | ARDX | Ardelyx, Inc. | 1.40B | -0.09% | 3,105,302 | 427.68M |
| 313 | GHRS | GH Research PLC | 1.40B | -3.55% | 159,501 | - |
| 314 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 1.42% | 389,136 | 1.30M |
| 315 | ARDT | Ardent Health, Inc. | 1.36B | 1.60% | 801,452 | 6.43B |
| 316 | IART | Integra LifeSciences Holdings Corporation | 1.36B | -1.74% | 891,529 | 1.64B |
| 317 | SVRA | Savara Inc. | 1.35B | 1.33% | 1,287,869 | - |
| 318 | TDOC | Teladoc Health, Inc. | 1.35B | 1.63% | 3,792,990 | 2.51B |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.91% | 635,368 | 20.00M |
| 320 | AHCO | AdaptHealth Corp. | 1.33B | -1.97% | 1,225,580 | 3.29B |
| 321 | ALVO | Alvotech | 1.32B | 1.68% | 641,282 | 562.04M |
| 322 | PRCT | PROCEPT BioRobotics Corporation | 1.32B | -9.68% | 3,210,757 | 322.02M |
| 323 | PAHC | Phibro Animal Health Corporation | 1.31B | 2.38% | 231,128 | 1.50B |
| 324 | BLFS | BioLife Solutions, Inc. | 1.30B | 2.26% | 829,402 | 101.66M |
| 325 | IMTX | Immatics N.V. | 1.29B | 0.53% | 163,448 | 43.00M |
| 326 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.28B | -0.40% | 2,916,015 | 204.73M |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.27B | 0.12% | 3,830,500 | 787.08M |
| 328 | MPLT | MapLight Therapeutics, Inc. | 1.27B | 0.76% | 204,942 | - |
| 329 | CDNA | CareDx, Inc. | 1.24B | 4.83% | 903,972 | 412.82M |
| 330 | INNV | InnovAge Holding Corp. | 1.24B | 0.66% | 331,325 | 949.17M |
| 331 | MNKD | MannKind Corporation | 1.24B | 9.29% | 5,605,230 | 360.78M |
| 332 | DMRA | Damora Therapeutics, Inc. | 1.24B | -3.42% | 590,607 | - |
| 333 | ENOV | Enovis Corporation | 1.21B | -3.76% | 845,447 | 2.28B |
| 334 | AVLN | Avalyn Pharma Inc. | 1.20B | -4.42% | 275,594 | - |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.20B | 0.26% | 1,251,186 | 3.42B |
| 336 | KMTS | Kestra Medical Technologies, Ltd. | 1.19B | -2.13% | 292,206 | 83.72M |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 1.33% | 2,169,741 | 314.85M |
| 338 | INSP | Inspire Medical Systems, Inc. | 1.19B | -3.68% | 1,042,031 | 915.25M |
| 339 | ZBIO | Zenas BioPharma, Inc. | 1.18B | -5.51% | 511,845 | 10.00M |
| 340 | AVNS | Avanos Medical, Inc. | 1.17B | - | 532,910 | 715.90M |
| 341 | IRMD | IRADIMED CORPORATION | 1.16B | -3.07% | 158,204 | 86.28M |
| 342 | WVE | Wave Life Sciences Ltd. | 1.15B | 2.21% | 2,357,532 | 71.80M |
| 343 | PNTG | The Pennant Group, Inc. | 1.15B | 0.58% | 197,898 | 1.02B |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 0.96% | 1,682,906 | 1.03B |
| 345 | AKTS | Aktis Oncology, Inc. | 1.14B | -5.65% | 488,906 | 8.28M |
| 346 | ABSI | Absci Corporation | 1.13B | 6.91% | 6,727,790 | 1.84M |
| 347 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | -1.30% | 408,095 | 796.33M |
| 348 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | 0.40% | 199,710 | - |
| 349 | DBVT | DBV Technologies S.A. | 1.09B | 4.02% | 175,872 | 5.74M |
| 350 | SDGR | Schrödinger, Inc. | 1.09B | 1.04% | 1,047,800 | 254.91M |
| 351 | AZTA | Azenta, Inc. | 1.06B | 1.59% | 739,057 | 596.48M |
| 352 | OPK | OPKO Health, Inc. | 1.06B | -1.41% | 2,596,923 | 581.12M |
| 353 | OMDA | Omada Health, Inc. | 1.03B | 1.11% | 901,200 | 283.30M |
| 354 | CNMD | CONMED Corporation | 1.03B | -1.75% | 619,025 | 1.37B |
| 355 | PSNL | Personalis, Inc. | 1.03B | 2.09% | 2,519,540 | 64.52M |
| 356 | AORT | Artivion, Inc. | 1.02B | 4.83% | 1,059,360 | 458.69M |
| 357 | EYPT | EyePoint, Inc. | 1.01B | -7.29% | 1,083,981 | 7.61M |
| 358 | NUTX | Nutex Health Inc. | 1.01B | 1.86% | 77,752 | 879.95M |
| 359 | EVO | Evotec SE | 1.01B | 2.94% | 34,552 | 859.03M |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | -0.25% | 707,767 | - |
| 361 | USPH | U.S. Physical Therapy, Inc. | 997.14M | -0.06% | 262,778 | 787.69M |
| 362 | AHG | Akso Health Group | 993.78M | -13.43% | 11,846 | 14.84M |
| 363 | QDEL | QuidelOrtho Corporation | 993.54M | 3.11% | 1,339,535 | 2.66B |
| 364 | CRON | Cronos Group Inc. | 986.39M | -1.87% | 1,083,196 | 159.54M |
| 365 | SPRY | ARS Pharmaceuticals, Inc. | 974.17M | 0.51% | 1,049,803 | 98.99M |
| 366 | JBIO | Jade Biosciences, Inc. | 955.69M | 4.95% | 1,295,785 | - |
| 367 | SPTX | Seaport Therapeutics, Inc. | 924.81M | -3.11% | 104,011 | - |
| 368 | GDRX | GoodRx Holdings, Inc. | 924.58M | 3.02% | 1,163,879 | 787.89M |
| 369 | PHAR | Pharming Group N.V. | 909.55M | 0.04% | 3,583 | 369.49M |
| 370 | AVR | Anteris Technologies Global Corp. | 906.68M | 2.95% | 855,469 | 1.85M |
| 371 | XNCR | Xencor, Inc. | 905.27M | -0.97% | 638,873 | 97.36M |
| 372 | MGTX | MeiraGTx Holdings plc | 902.94M | 1.67% | 634,638 | 79.76M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 902.20M | -2.59% | 784,073 | 1.03B |
| 374 | PCRX | Pacira BioSciences, Inc. | 894.77M | -1.09% | 350,777 | 734.86M |
| 375 | BIOA | BioAge Labs, Inc. | 881.94M | 9.98% | 747,095 | 10.32M |
| 376 | ETON | Eton Pharmaceuticals, Inc. | 880.66M | 1.77% | 265,866 | 86.93M |
| 377 | DRTS | Alpha Tau Medical Ltd. | 872.00M | -1.83% | 668,544 | - |
| 378 | TALK | Talkspace, Inc. | 871.07M | -0.19% | 2,704,723 | 238.37M |
| 379 | LXRX | Lexicon Pharmaceuticals, Inc. | 870.62M | 2.08% | 2,081,545 | 69.64M |
| 380 | ORIC | ORIC Pharmaceuticals, Inc. | 869.55M | 1.57% | 1,241,463 | - |
| 381 | AMPH | Amphastar Pharmaceuticals, Inc. | 869.07M | -1.89% | 528,512 | 720.53M |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 862.99M | 0.10% | 1,322,014 | - |
| 383 | INMD | InMode Ltd. | 859.78M | 0.89% | 673,039 | 374.64M |
| 384 | SANA | Sana Biotechnology, Inc. | 854.71M | 6.34% | 2,785,951 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 853.36M | 1.41% | 1,097,026 | 191.45M |
| 386 | PHAT | Phathom Pharmaceuticals, Inc. | 850.70M | 3.28% | 692,080 | 204.89M |
| 387 | KURA | Kura Oncology, Inc. | 846.91M | 5.41% | 1,680,613 | 71.64M |
| 388 | TBPH | Theravance Biopharma, Inc. | 841.35M | -1.92% | 346,348 | 109.78M |
| 389 | JANX | Janux Therapeutics, Inc. | 837.93M | 1.33% | 574,655 | 13.73M |
| 390 | CGEM | Cullinan Therapeutics, Inc. | 836.44M | -0.66% | 1,790,102 | - |
| 391 | ODTX | Odyssey Therapeutics, Inc. | 832.62M | 4.44% | 278,232 | 2.98M |
| 392 | LBRX | LB Pharmaceuticals Inc | 817.28M | 0.28% | 201,997 | - |
| 393 | ESPR | Esperion Therapeutics, Inc. | 810.91M | - | 8,827,427 | 418.24M |
| 394 | CERT | Certara, Inc. | 810.49M | 0.19% | 4,205,617 | 419.75M |
| 395 | IVA | Inventiva S.A. | 788.03M | -2.34% | 350,663 | 7.94M |
| 396 | AVTX | Avalo Therapeutics, Inc. | 767.46M | -1.08% | 950,167 | 59.00K |
| 397 | VOR | Vor Biopharma Inc. | 762.40M | -2.02% | 1,913,073 | - |
| 398 | ANNX | Annexon, Inc. | 760.23M | -1.49% | 2,898,247 | - |
| 399 | HSTM | HealthStream, Inc. | 755.80M | -1.00% | 151,835 | 311.78M |
| 400 | EVMN | Evommune, Inc. | 750.62M | 5.09% | 447,756 | 10.00M |
| 401 | ANRO | Alto Neuroscience, Inc. | 742.94M | -1.40% | 246,761 | - |
| 402 | ZVRA | Zevra Therapeutics, Inc. | 741.89M | -0.79% | 1,873,003 | 122.29M |
| 403 | REPL | Replimune Group, Inc. | 739.85M | 0.90% | 1,980,788 | - |
| 404 | NNNN | Anbio Biotechnology | 737.81M | 7.83% | 19,806 | 8.65M |
| 405 | GERN | Geron Corporation | 737.75M | - | 9,845,349 | 196.12M |
| 406 | SLDB | Solid Biosciences Inc. | 724.59M | 3.08% | 2,064,034 | - |
| 407 | BVS | Bioventus Inc. | 718.40M | 1.06% | 632,349 | 576.30M |
| 408 | AURA | Aura Biosciences, Inc. | 711.43M | 0.62% | 581,891 | - |
| 409 | CBLL | CeriBell, Inc. | 705.35M | 0.65% | 233,616 | 95.07M |
| 410 | SSII | SS Innovations International, Inc. | 704.46M | 4.76% | 93,087 | 48.47M |
| 411 | OCS | Oculis Holding AG | 701.11M | 4.69% | 759,945 | 1.40M |
| 412 | DSGN | Design Therapeutics, Inc. | 695.77M | 1.55% | 823,822 | - |
| 413 | TENX | Tenax Therapeutics, Inc. | 680.04M | 0.61% | 759,632 | - |
| 414 | OMER | Omeros Corporation | 675.26M | 6.75% | 1,960,053 | 9.89M |
| 415 | CRMD | CorMedix Inc. | 673.90M | -1.72% | 1,412,722 | 400.05M |
| 416 | SIBN | SI-BONE, Inc. | 670.56M | -1.95% | 649,296 | 206.22M |
| 417 | ALLO | Allogene Therapeutics, Inc. | 669.60M | 2.11% | 5,800,149 | 22.00K |
| 418 | RLMD | Relmada Therapeutics, Inc. | 668.15M | -4.21% | 3,076,359 | - |
| 419 | CTMX | CytomX Therapeutics, Inc. | 661.82M | 1.00% | 2,921,561 | 35.54M |
| 420 | GMRS | GMR Solutions Inc. | 649.76M | -2.59% | 646,165 | 5.83B |
| 421 | BBNX | Beta Bionics, Inc. | 640.80M | -1.03% | 941,748 | 110.24M |
| 422 | SGP | SpyGlass Pharma, Inc. | 633.10M | 2.71% | 143,815 | - |
| 423 | CADL | Candel Therapeutics, Inc. | 627.19M | - | 1,628,143 | - |
| 424 | CSTL | Castle Biosciences, Inc. | 626.62M | -0.19% | 220,462 | 339.92M |
| 425 | TRAX | First Tracks Biotherapeutics, Inc. | 623.88M | 1.36% | 484,306 | - |
| 426 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 619.23M | -0.26% | 344,677 | - |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 618.34M | 1.74% | 278,419 | 299.77M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 608.93M | 0.93% | 1,675,623 | 8.37M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 607.42M | 1.10% | 2,004,919 | 361.51M |
| 430 | CBIO | Crescent Biopharma, Inc. | 604.44M | 1.51% | 179,387 | 11.88M |
| 431 | TLRY | Tilray Brands, Inc. | 597.61M | 0.60% | 3,904,413 | 858.28M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 594.58M | 0.19% | 150,297 | 343.52M |
| 433 | DRUG | Bright Minds Biosciences Inc. | 592.93M | -2.92% | 938,932 | - |
| 434 | IMMX | Immix Biopharma, Inc. | 591.13M | 0.24% | 970,592 | - |
| 435 | BWAY | BrainsWay Ltd. | 581.67M | -2.05% | 84,567 | 56.22M |
| 436 | ACHV | Achieve Life Sciences, Inc. | 574.89M | 1.45% | 1,944,935 | - |
| 437 | PHR | Phreesia, Inc. | 565.58M | 0.99% | 1,152,271 | 495.59M |
| 438 | TECX | Tectonic Therapeutic, Inc. | 554.57M | -2.94% | 103,598 | - |
| 439 | CLYM | Climb Bio, Inc. | 548.86M | 0.44% | 1,177,950 | - |
| 440 | MDXG | MiMedx Group, Inc. | 548.12M | 2.22% | 1,077,219 | 389.42M |
| 441 | DNA | Ginkgo Bioworks Holdings, Inc. | 537.62M | 4.31% | 651,928 | 151.40M |
| 442 | VRXA | VERAXA Biotech AG | 536.12M | 6.30% | 59,875 | - |
| 443 | GYRE | Gyre Therapeutics, Inc. | 535.44M | -1.69% | 57,131 | 117.05M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 529.40M | 1.20% | 1,309,618 | 50.27M |
| 445 | EVH | Evolent Health, Inc. | 528.66M | -2.08% | 2,691,619 | 1.89B |
| 446 | XOMA | XOMA Royalty Corporation | 526.10M | 0.38% | 108,394 | 48.56M |
| 447 | NPCE | NeuroPace, Inc. | 524.02M | -1.73% | 191,928 | 99.53M |
| 448 | PRME | Prime Medicine, Inc. | 523.79M | 4.50% | 2,913,489 | 4.03M |
| 449 | CTEV | Claritev Corporation | 521.83M | -0.91% | 94,235 | 978.76M |
| 450 | FLGT | Fulgent Genetics, Inc. | 521.15M | -1.77% | 197,645 | 320.35M |
| 451 | TOI | The Oncology Institute, Inc. | 517.91M | -2.45% | 2,520,776 | 545.76M |
| 452 | ALT | Altimmune, Inc. | 513.41M | 1.15% | 3,516,863 | 36.00K |
| 453 | SRTA | Strata Critical Medical, Inc. | 509.64M | 8.47% | 1,891,921 | 228.58M |
| 454 | CTKB | Cytek Biosciences, Inc. | 507.53M | -0.76% | 1,551,444 | 204.17M |
| 455 | EIKN | Eikon Therapeutics, Inc. | 505.11M | 6.63% | 316,010 | - |
| 456 | CERS | Cerus Corporation | 504.93M | -1.56% | 2,117,606 | 216.56M |
| 457 | PROK | ProKidney Corp. | 504.44M | 1.83% | 570,256 | 889.00K |
| 458 | VALN | Valneva SE | 504.32M | 0.56% | 14,958 | 180.25M |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 460 | STRO | Sutro Biopharma, Inc. | 500.43M | 4.86% | 188,635 | 99.61M |
| 461 | ANGO | AngioDynamics, Inc. | 499.35M | -0.99% | 333,911 | 313.73M |
| 462 | KYTX | Kyverna Therapeutics, Inc. | 493.32M | 1.12% | 580,963 | - |
| 463 | AGMB | AgomAb Therapeutics NV | 492.48M | 4.06% | 158,906 | - |
| 464 | CABA | Cabaletta Bio, Inc. | 490.79M | - | 3,241,701 | - |
| 465 | ARVN | Arvinas, Inc. | 483.26M | -1.19% | 575,600 | 89.40M |
| 466 | FDMT | 4D Molecular Therapeutics, Inc. | 481.99M | 4.42% | 1,064,885 | 88.24M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 475.55M | 7.07% | 430,242 | - |
| 468 | NGNE | Neurogene Inc. | 471.84M | 2.61% | 116,269 | 925.00K |
| 469 | KIDS | OrthoPediatrics Corp. | 466.18M | 1.85% | 164,128 | 243.30M |
| 470 | ASMB | Assembly Biosciences, Inc. | 461.94M | 1.52% | 173,207 | 71.10M |
| 471 | ANL | Adlai Nortye Ltd. | 453.20M | 9.79% | 144,353 | 5.00M |
| 472 | RZLT | Rezolute, Inc. | 452.34M | 8.25% | 2,398,386 | - |
| 473 | ARTV | Artiva Biotherapeutics, Inc. | 446.04M | 7.49% | 782,327 | 251.00K |
| 474 | EOLS | Evolus, Inc. | 444.52M | 0.30% | 904,162 | 301.79M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 442.33M | -0.67% | 327,389 | 16.72M |
| 476 | FBRX | Forte Biosciences, Inc. | 441.06M | 1.99% | 124,992 | - |
| 477 | VREX | Varex Imaging Corporation | 440.01M | -5.43% | 262,396 | 857.50M |
| 478 | KMDA | Kamada Ltd. | 433.93M | 0.27% | 18,643 | 181.68M |
| 479 | WEAV | Weave Communications, Inc. | 432.84M | -1.45% | 1,189,187 | 248.72M |
| 480 | EBS | Emergent BioSolutions Inc. | 427.73M | -0.36% | 688,706 | 676.80M |
| 481 | PRTA | Prothena Corporation plc | 426.68M | -1.21% | 622,611 | 57.94M |
| 482 | CCCC | C4 Therapeutics, Inc. | 422.37M | -2.05% | 1,558,119 | 34.86M |
| 483 | OVID | Ovid Therapeutics Inc. | 421.81M | -1.74% | 1,843,192 | 7.12M |
| 484 | INDP | Indaptus Therapeutics, Inc. | 417.86M | 3.07% | 378,878 | - |
| 485 | VTVT | vTv Therapeutics Inc. | 416.22M | 2.37% | 52,198 | 36.84M |
| 486 | CYH | Community Health Systems, Inc. | 415.84M | -1.60% | 906,495 | 12.29B |
| 487 | IPSC | Century Therapeutics, Inc. | 414.82M | 2.22% | 1,081,582 | 109.16M |
| 488 | OCGN | Ocugen, Inc. | 413.00M | 0.83% | 6,340,361 | 4.47M |
| 489 | NRC | NRC Health | 412.65M | -2.77% | 109,664 | 138.64M |
| 490 | MNPR | Monopar Therapeutics Inc. | 411.77M | 2.84% | 154,175 | - |
| 491 | PACB | Pacific Biosciences of California, Inc. | 409.99M | 0.76% | 5,298,162 | 160.03M |
| 492 | CCRN | Cross Country Healthcare, Inc. | 408.38M | - | 258,310 | 1.00B |
| 493 | MYGN | Myriad Genetics, Inc. | 408.02M | -0.23% | 1,128,269 | 829.00M |
| 494 | EPRX | Eupraxia Pharmaceuticals Inc. | 407.52M | 2.98% | 256,267 | - |
| 495 | DCTH | Delcath Systems, Inc. | 407.01M | 0.60% | 450,959 | 90.44M |
| 496 | CLPT | ClearPoint Neuro, Inc. | 405.46M | 0.60% | 325,358 | 40.61M |
| 497 | VMD | Viemed Healthcare, Inc. | 400.24M | -0.10% | 223,399 | 286.57M |
| 498 | SGMT | Sagimet Biosciences Inc. | 399.53M | -0.15% | 605,457 | - |
| 499 | AUTL | Autolus Therapeutics plc | 399.21M | -3.85% | 1,277,599 | 92.62M |
| 500 | BNTC | Benitec Biopharma Inc. | 389.23M | 1.34% | 83,049 | - |